Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125960202 | 12596020 | 2 | F | 201605 | 20160516 | 20160726 | 20160922 | PER | US-AMGEN-USASL2016062633 | AMGEN | 76.00 | YR | E | M | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125960202 | 12596020 | 1 | PS | KYPROLIS | CARFILZOMIB | 1 | Unknown | UNK | U | 202714 | INTRAVENOUS INFUSION | ||||||||
125960202 | 12596020 | 2 | SS | NEUPOGEN | FILGRASTIM | 1 | Unknown | UNK | U | 0 | UNKNOWN FORMULATION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125960202 | 12596020 | 1 | Plasma cell myeloma |
125960202 | 12596020 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125960202 | 12596020 | Arthritis | |
125960202 | 12596020 | Chest discomfort | |
125960202 | 12596020 | Condition aggravated | |
125960202 | 12596020 | Dyspnoea | |
125960202 | 12596020 | Fatigue | |
125960202 | 12596020 | Incorrect product storage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125960202 | 12596020 | 1 | 20160509 | 0 | ||
125960202 | 12596020 | 2 | 20160509 | 0 |